Oura Ring Gen 4 sensor data, not clinical measurementsN=1 case study, not validated for clinical decisionsHEV diagnosed Mar 18; Day 223 post-ruxolitinibMore
Consumer wearable data can support exploratory review only. The HEV diagnosis, temporally confounded with treatment start, remains a material confounder.

Weekly Tracker

2026-10-18 to 2026-10-24
GREEN
On Track
8
Metrics in normal range
AMBER
Watch
2
Borderline or declining
RED
Alert
2
Needs attention
IMPROVING
In range
2
Week-over-week
DECLINING
Alert
6
Week-over-week

Doctor Summary - Week of 2026-10-18 to 2026-10-24

  • ATTENTION: Deep Sleep is declining at 1.1 h (-10.3% week-over-week)
  • ATTENTION: Steps is declining at 2709 steps (-37.3% week-over-week)
  • Temp Deviation improved -19.4% to 0.11 °C
  • Recovery Index improved +7.5% to 59 pts
  • Readiness Score declined -5.3% to 64 pts -- monitor
METRICS

Metric Details

HRV (RMSSD)
16.9ms
↓ -4.8%Last week: 17.7 ms
Lowest HR
63.6bpm
↔ +1.6%Last week: 62.6 bpm
Average HR
71.4bpm
↔ +0.4%Last week: 71.2 bpm
Sleep Duration
6.3h
↓ -5.2%Last week: 6.7 h
Deep Sleep
1.1h
↓ -10.3%Last week: 1.2 h
REM Sleep
1.2h
↔ -2.2%Last week: 1.3 h
Sleep Efficiency
81%
↓ -3.4%Last week: 83 %
Readiness Score
64pts
↓ -5.3%Last week: 67 pts
Recovery Index
59pts
↑ +7.5%Last week: 55 pts
Steps
2709steps
↓ -37.3%Last week: 4318 steps
Temp Deviation
0.11°C
↑ -19.4%Last week: 0.14 °C
Breath Rate
14.1brpm
↔ +2.6%Last week: 13.7 brpm
RUXOLITINIB

Ruxolitinib Progress

Day 222 on ruxolitinib (started 2026-03-16)

MetricPre-Rux BaselineThis WeekChange
HRV (RMSSD)11.7 ms16.9 ms↑ +43.9%
Lowest HR73.0 bpm63.6 bpm↓ -12.9%
Average HR80.5 bpm71.4 bpm↓ -11.2%
Sleep Duration6.0 h6.3 h↑ +6.0%
Deep Sleep1.0 h1.1 h↑ +8.0%
REM Sleep0.8 h1.2 h↑ +45.7%
Sleep Efficiency79 %81 %↑ +2.0%
Readiness Score69 pts64 pts↓ -7.8%
Recovery Index63 pts59 pts↓ -6.0%
Steps2540 steps2709 steps↑ +6.6%
Temp Deviation0.21 °C0.11 °C↓ -45.1%
Breath Rate14.0 brpm14.1 brpm↑ +0.9%